Can Candrol be taken with Chemotherapy and Radiations without any contradiction?
ANOTHER IMPORTANT ISSUE IS WHETHER CANDROLTM DO ANY IMPAIRMENT WITH CONVENTIONAL TREATMENTS LIKE CHEMOTHERAPY OR RADIATION THERAPY?
The answer is absolutely YES! CandrolTM is a molecular medicine which is very individualised according to one particular case and the combinations are prepared according to the status of disease and taking into consideration various disease parameters like loss of function, extent of metastasis i.e F.D.G UPTAKE IN PET SCANS..doses of radiations which the patient has undergone and on what and how many chemotherapy cycles the patient has been put on in past.So depending on these some factors and many others, line of treatment is to be selected taking highly potentized drugs which have no materialistic quantity of original drug substance,thus the chances of materialistic interference with any chemotherapy cycle or radiation cycles becomes 0%. Rather it has been evaluated and observed in past clinical observation that CandrolTM bears very high potential in nullifying all the side-effects of conventional treatments. Which can be experienced by the patients after taking few doses of this molecular medicine. Cases like NSC LUNG (non small cell carcinoma) and SCC LUNG (small cell carcinoma) are the milestones showing tremendous response with CandrolTM even in those cases which have become either irresponsible or resistant with chemotherapy or in patients who either does not want to opt for chemotherapy or in cases where chemotherapy cannot be given due to numerous reasons like disturbed blood pictures.
The efficacy of CandrolTM now is indisputable and it is readily accepted side by side along with every conventional cancer treatment modality in across 100 countries in the globe.the strength of effectiveness can only be measured by the patients those who have opted for CandrolTM as the adjuvant treatment and also as an independent line of treatment , or by experiencing the effect of this molecular medicine by taking it. The research is still on by Dr. Rishi Sharma and his team and consent efforts are being made to make it still powerful modality in those domains of practice of medicine where it fails to respond in some cases